Clinical trials
Withdrawn Phase 1 Carcinoma, Hepatocellular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abramson Cancer Center at Penn Medicine | 1 |
| Baylor College of Medicine | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Indiana University | 1 |
| Jiujiang University Affiliated Hospital | 1 |
| Johns Hopkins University | 1 |
| Lee's Pharmaceutical Limited | 1 |
| Massachusetts General Hospital | 1 |
| Mayo Clinic | 1 |
| Medical College of Wisconsin | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 14 |
| Glioblastoma | 2 |
| Liver Neoplasms | 2 |
| Carcinoma, Renal Cell | 1 |
| Colonic Neoplasms | 1 |
| Fibrosis | 1 |
| Hepatoblastoma | 1 |
| Liver Diseases | 1 |
| Medulloblastoma | 1 |
| Neoplasm Metastasis | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.